Tal Y - Search Results

1

Transgenic over-expression of mammalian heparanase delays prion disease onset and progression.

Kovalchuk Ben-Zaken O, Nissan I, Tzaban S, Taraboulos A, Zcharia E, Matzger S, Shafat I, Vlodavsky I, Tal Y. Kovalchuk Ben-Zaken O, et al. Among authors: tal y. Biochem Biophys Res Commun. 2015 Aug 28;464(3):698-704. doi: 10.1016/j.bbrc.2015.06.170. Epub 2015 Jul 10. Biochem Biophys Res Commun. 2015. PMID: 26168721 Free PMC article.

2

Modulation of proteinase-K resistant prion protein by prion peptide immunization.

Souan L, Tal Y, Felling Y, Cohen IR, Taraboulos A, Mor F. Souan L, et al. Among authors: tal y. Eur J Immunol. 2001 Aug;31(8):2338-46. doi: 10.1002/1521-4141(200108)31:8<2338::aid-immu2338>3.0.co;2-v. Eur J Immunol. 2001. PMID: 11477546 Free article.

3

Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice.

Tal Y, Souan L, Cohen IR, Meiner Z, Taraboulos A, Mor F. Tal Y, et al. J Neurosci Res. 2003 Jan 15;71(2):286-90. doi: 10.1002/jnr.10474. J Neurosci Res. 2003. PMID: 12503092

4

Cellular heparan sulfate participates in the metabolism of prions.

Ben-Zaken O, Tzaban S, Tal Y, Horonchik L, Esko JD, Vlodavsky I, Taraboulos A. Ben-Zaken O, et al. Among authors: tal y. J Biol Chem. 2003 Oct 10;278(41):40041-9. doi: 10.1074/jbc.M301152200. Epub 2003 Jul 18. J Biol Chem. 2003. PMID: 12871949 Free article.

5

Methylphenidate prolongs symptom-free period of experimental prion disease in mice.

Nissan I, Gahali-Sass I, Rouvinski A, Makedonski K, Taraboulos A, Tal Y. Nissan I, et al. Among authors: tal y. J Neurol Sci. 2015 Apr 15;351(1-2):204-205. doi: 10.1016/j.jns.2015.02.040. Epub 2015 Feb 28. J Neurol Sci. 2015. PMID: 25748967 No abstract available.

6

Cogan's syndrome--clinical guidelines and novel therapeutic approaches.

Tayer-Shifman OE, Ilan O, Tovi H, Tal Y. Tayer-Shifman OE, et al. Among authors: tal y. Clin Rev Allergy Immunol. 2014 Aug;47(1):65-72. doi: 10.1007/s12016-013-8406-7. Clin Rev Allergy Immunol. 2014. PMID: 24385257 Review.

7

B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodies.

Fox-Fisher I, Piyanzin S, Briller M, Oiknine-Djian E, Alfi O, Ben-Ami R, Peretz A, Neiman D, Ochana BL, Fridlich O, Drawshy Z, Klochendler A, Magenheim J, Share D, Avrahami R, Ribak Y, Talmon A, Rubin L, Milman N, Segev M, Feldman E, Tal Y, Shen-Orr SS, Glaser B, Shemer R, Wolf D, Dor Y. Fox-Fisher I, et al. Among authors: tal y. Med. 2022 Jul 8;3(7):468-480.e5. doi: 10.1016/j.medj.2022.05.005. Epub 2022 May 19. Med. 2022. PMID: 35716665 Free PMC article.

8

Autoimmune Inner Ear Disease: Immune Biomarkers, Audiovestibular Aspects, and Therapeutic Modalities of Cogan's Syndrome.

Shamriz O, Tal Y, Gross M. Shamriz O, et al. Among authors: tal y. J Immunol Res. 2018 Apr 23;2018:1498640. doi: 10.1155/2018/1498640. eCollection 2018. J Immunol Res. 2018. PMID: 29850616 Free PMC article. Review.

9

γδT Cells Are Essential for Orthodontic Tooth Movement.

Wald S, Leibowitz A, Aizenbud Y, Saba Y, Zubeidat K, Barel O, Koren N, Heyman O, Wilharm A, Sandrock I, Fleissig O, Tal Y, Prinz I, Aizenbud D, Chaushu S, Hovav AH. Wald S, et al. Among authors: tal y. J Dent Res. 2021 Jul;100(7):731-738. doi: 10.1177/0022034520984774. Epub 2021 Jan 21. J Dent Res. 2021. PMID: 33478315

10

Reduced in vitro response to concanavalin A and lipopolysaccharide in senescent mice: a function of reduced number of responding cells.

Abraham C, Tal Y, Gershon H. Abraham C, et al. Among authors: tal y. Eur J Immunol. 1977 May;7(5):301-4. doi: 10.1002/eji.1830070512. Eur J Immunol. 1977. PMID: 301478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters